MX9200620A - Composicion farmaceutica y metodo para retardar la degeneracion de celulas nerviosas. - Google Patents
Composicion farmaceutica y metodo para retardar la degeneracion de celulas nerviosas.Info
- Publication number
- MX9200620A MX9200620A MX9200620A MX9200620A MX9200620A MX 9200620 A MX9200620 A MX 9200620A MX 9200620 A MX9200620 A MX 9200620A MX 9200620 A MX9200620 A MX 9200620A MX 9200620 A MX9200620 A MX 9200620A
- Authority
- MX
- Mexico
- Prior art keywords
- degeneration
- delaying
- pharmaceutical composition
- nervous cells
- treatment
- Prior art date
Links
- 230000007850 degeneration Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000001777 nootropic effect Effects 0.000 abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- WZXHSWVDAYOFPE-UHFFFAOYSA-N brofaromine Chemical compound C=1C2=CC(OC)=CC(Br)=C2OC=1C1CCNCC1 WZXHSWVDAYOFPE-UHFFFAOYSA-N 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 239000002664 nootropic agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH47091 | 1991-02-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9200620A true MX9200620A (es) | 1992-08-01 |
Family
ID=4187740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9200620A MX9200620A (es) | 1991-02-15 | 1992-02-13 | Composicion farmaceutica y metodo para retardar la degeneracion de celulas nerviosas. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0499586B1 (es) |
| JP (1) | JPH0570352A (es) |
| KR (1) | KR920016098A (es) |
| AT (1) | ATE138805T1 (es) |
| AU (1) | AU655227B2 (es) |
| CA (1) | CA2061015A1 (es) |
| DE (1) | DE59206442D1 (es) |
| DK (1) | DK0499586T3 (es) |
| ES (1) | ES2087497T3 (es) |
| GR (1) | GR3020155T3 (es) |
| IE (1) | IE74906B1 (es) |
| IL (1) | IL100889A (es) |
| MX (1) | MX9200620A (es) |
| NO (1) | NO179358C (es) |
| NZ (1) | NZ241608A (es) |
| ZA (1) | ZA921091B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3595093A (en) * | 1992-02-21 | 1993-09-13 | Ciba-Geigy Ag | Brofaromine as an agent for treating social phobia |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2938463B2 (ja) * | 1987-10-22 | 1999-08-23 | マサチユセツツ・インスチチユート・オブ・テクノロジー | 月経前又は後期黄体期症候群の処置 |
-
1992
- 1992-02-06 ES ES92810085T patent/ES2087497T3/es not_active Expired - Lifetime
- 1992-02-06 EP EP92810085A patent/EP0499586B1/de not_active Expired - Lifetime
- 1992-02-06 DK DK92810085.8T patent/DK0499586T3/da active
- 1992-02-06 DE DE59206442T patent/DE59206442D1/de not_active Expired - Fee Related
- 1992-02-06 IL IL100889A patent/IL100889A/xx not_active IP Right Cessation
- 1992-02-06 AT AT92810085T patent/ATE138805T1/de not_active IP Right Cessation
- 1992-02-10 AU AU10877/92A patent/AU655227B2/en not_active Ceased
- 1992-02-13 MX MX9200620A patent/MX9200620A/es not_active IP Right Cessation
- 1992-02-13 CA CA002061015A patent/CA2061015A1/en not_active Abandoned
- 1992-02-13 KR KR1019920002074A patent/KR920016098A/ko not_active Abandoned
- 1992-02-13 NZ NZ241608A patent/NZ241608A/en unknown
- 1992-02-14 NO NO920591A patent/NO179358C/no unknown
- 1992-02-14 ZA ZA921091A patent/ZA921091B/xx unknown
- 1992-02-14 IE IE920486A patent/IE74906B1/en not_active IP Right Cessation
- 1992-02-14 JP JP4028252A patent/JPH0570352A/ja active Pending
-
1996
- 1996-06-06 GR GR960401246T patent/GR3020155T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE74906B1 (en) | 1997-08-13 |
| JPH0570352A (ja) | 1993-03-23 |
| EP0499586A1 (de) | 1992-08-19 |
| GR3020155T3 (en) | 1996-09-30 |
| NO179358B (no) | 1996-06-17 |
| EP0499586B1 (de) | 1996-06-05 |
| IE920486A1 (en) | 1992-08-26 |
| ES2087497T3 (es) | 1996-07-16 |
| NO920591D0 (no) | 1992-02-14 |
| AU1087792A (en) | 1992-08-20 |
| IL100889A (en) | 1997-03-18 |
| IL100889A0 (en) | 1992-11-15 |
| ZA921091B (en) | 1992-09-30 |
| KR920016098A (ko) | 1992-09-24 |
| AU655227B2 (en) | 1994-12-08 |
| NO920591L (no) | 1992-08-17 |
| NZ241608A (en) | 1997-06-24 |
| DE59206442D1 (de) | 1996-07-11 |
| NO179358C (no) | 1996-09-25 |
| CA2061015A1 (en) | 1992-08-16 |
| ATE138805T1 (de) | 1996-06-15 |
| DK0499586T3 (da) | 1996-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0574313T3 (da) | 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme | |
| DK0725779T3 (da) | Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner | |
| AU2118488A (en) | Improvements in or relating to methods of treating damaged skin | |
| UA27749C2 (uk) | Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі | |
| NO941884D0 (no) | 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler | |
| AU635326B2 (en) | A method for cultivating cells in microporous beads | |
| FI940696A0 (fi) | Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö | |
| WO1992007832A3 (en) | Substituted piperazines as central nervous system agents | |
| CA2107552A1 (en) | Use of deprenyl to maintain, prevent loss, or recover nerve cell function | |
| ES2054718T3 (es) | El uso de gepirona para la preparacion de una composicion farmaceutica para el tratamiento de la depresion atipica. | |
| IL113411A (en) | Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition | |
| IT1256320B (it) | Derivati eterociclici | |
| MX9200620A (es) | Composicion farmaceutica y metodo para retardar la degeneracion de celulas nerviosas. | |
| DK0431579T3 (da) | Substituerede cyclohexener som midler med virkning på centralnervesystemet | |
| DE10299023I1 (de) | Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff | |
| NZ233618A (en) | Optionally heterocyclic substituted pyrrolidone derivatives and pharmaceutical compositions | |
| MX9204905A (es) | Acidos aminometanodifosfonicos n-substituidos y procedimiento para su obtencion | |
| BR0016168A (pt) | Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos | |
| ES2001104A6 (es) | Un procedimiento para la preparacion de nuevos derivados sustituidos del acido 1,4-dihidro-3,5-piridindicarboxilico. | |
| AU4831279A (en) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |